Advertisement

Current Cardiology Reports

, 15:426 | Cite as

Acute Hypertensive Response Management in Patients with Acute Stroke

  • Syeda L. AlqadriEmail author
  • Varun Sreenivasan
  • Adnan I. Qureshi
Stroke (C Sila, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Stroke

Abstract

Acute elevation in blood pressure (acute hypertensive response) is commonly observed in the early period of both ischemic and hemorrhagic stroke. The management of acute hypertensive response depends upon the underlying intracranial pathology. Management of acute hypertensive response has been the focus of many trials and studies such as the SCAST trial, CHHIPS trial, COSSACS trial, INTERACT, and ATACH trial, which are discussed here. However, there were many limitations to these trials including time of presentation, different pathophysiology of ischemic strokes versus hemorrhagic strokes, and patient related factors. Ongoing clinical trials which take these limitations into account include ENCHANTED trial, ATACH II trial, INTERACT 2 trial, and ENOS trial. The results of these trials are expected to modify current guidelines of acute stroke, both ischemic and hemorrhagic, and potentially improve clinical outcomes and quality of life.

Keywords

Acute ischemic stroke Blood pressure Intracerebral hemorrhage Hypertensive response Penumbra Hematoma Management 

Notes

Compliance with Ethics Guidelines

Conflict of Interest

Syeda L. Alqadri, Varun Sreenivasan, and Adnan I. Qureshi declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Qureshi AI, Ezzeddine MA, Nasar A, Suri MF, Kirmani JF, Hussein HM, et al. Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med. 2007;25(1):32–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Arboix A, Roig H, Rossich R, Martinez EM, Garcia-Eroles L. Differences between hypertensive and non-hypertensive ischemic stroke. Eur J Neurol. 2004;11(10):687–92.PubMedCrossRefGoogle Scholar
  3. 3.
    Patarroyo SX, Anderson C. Blood pressure lowering in acute phase of stroke: latest evidence and clinical implications. Ther Adv Chronic Dis. 2012;3(4):163–71. doi: 10.1177/2040622312450183.PubMedCrossRefGoogle Scholar
  4. 4.
    Qureshi AI. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation. 2008;118(2):176–87.PubMedCrossRefGoogle Scholar
  5. 5.
    Orlandi G, Fanucchi S, Strata G, Pataleo L, Landucci Pellegrini L, Prontera C, et al. Transient autonomic nervous system dysfunction during hyperacute stroke. Acta Neurol Scand. 2000;102(5):317–21.PubMedCrossRefGoogle Scholar
  6. 6.
    Lattanzi S, Silvestrini M, Provinciali L. Elevated blood pressure in the acute phase of stroke and the role of Angiotensin receptor blockers. Int J Hypertens. 2013;2013:941783. doi: 10.1155/2013/941783.PubMedGoogle Scholar
  7. 7.
    Sandset EC, Bath PM, Boysen G, Jatuzis D, Korv J, Luders S, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet. 2011;377(9767):741–50. doi: 10.1016/S0140-6736(11)60104-9.PubMedCrossRefGoogle Scholar
  8. 8.
    Potter JF, Robinson TG, Ford GA, Mistri A, James M, Chernova J, et al. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol. 2009;8(1):48–56. doi: 10.1016/S1474-4422(08)70263-1.PubMedCrossRefGoogle Scholar
  9. 9.
    Robinson TG, Potter JF, Ford GA, Bulpitt CJ, Chernova J, Jagger C, et al. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol. 2010;9(8):767–75. doi: 10.1016/S1474-4422(10)70163-0.PubMedCrossRefGoogle Scholar
  10. 10.
    Anderson CS, Huang Y, Wang JG, Arima H, Neal B, Peng B, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7(5):391–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Anderson CS, Huang Y, Arima H, Heeley E, Skulina C, Parsons MW, et al. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). Stroke. 2010;41(2):307–12. doi: 10.1161/STROKEAHA.109.561795.PubMedCrossRefGoogle Scholar
  12. 12.
    •• Qureshi A, Palesch Y. Expansion of recruitment time window in antihypertensive treatment of acute cerebral hemorrhage (ATACH) II trial. J Vasc Interv Neurol. 2012;5(supp):6–9. This is an ongoing trial which evaluates the efficacy of early, intensive, antihypertensive treatment using intravenous nicardipine initiated within 3 h of onset of intracerebral hemorrhage.Google Scholar
  13. 13.
    • Delcourt C, Huang Y, Wang J, Heeley E, Lindley R, Stapf C, et al. The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT2). Int J Stroke. 2010;5(2):110–6. doi: 10.1111/j.1747-4949.2010.00415. This is the main phase trial which evaluates early intensive blood pressure lowering and effects on hematoma expansion within 6 h of onset of intracerebral hemorrhage.PubMedCrossRefGoogle Scholar
  14. 14.
    Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122). Int J Stroke. 2006;1(4):245–9. doi: 10.1111/j.1747-4949.2006.00059.x.
  15. 15.
    Qureshi AI, Palesch YY, Martin R, Novitzke J, Cruz-Flores S, Ehtisham A, et al. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study. Arch Neurol. 2010;67(5):570–6. doi: 10.1001/archneurol.2010.61.PubMedCrossRefGoogle Scholar
  16. 16.
    Antihypertensive treatment of acute cerebral hemorrhage. Crit Care Med. 2010;38(2):637–48. doi: 10.1097/CCM.0b013e3181b9e1a5.Google Scholar
  17. 17.
    Anderson C. Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED). 2011. http://clinicaltrials.gov/show/NCT01422616. Accessed 06/20/2013.
  18. 18.
    Jauch EC, Saver JL, Adams Jr HP, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947. doi: 10.1161/STR.0b013e318284056a.PubMedCrossRefGoogle Scholar
  19. 19.
    Broderick JP, Adams Jr HP, Barsan W, Feinberg W, Feldmann E, Grotta J, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1999;30(4):905–15.PubMedCrossRefGoogle Scholar
  20. 20.
    Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344(19):1450–60. doi: 10.1056/NEJM200105103441907.PubMedCrossRefGoogle Scholar
  21. 21.
    Jung SY, Choi NK, Kim JY, Chang Y, Song HJ, Lee J, et al. Short-acting nifedipine and risk of stroke in elderly hypertensive patients. Neurology. 2011;77(13):1229–34. doi: 10.1212/WNL.0b013e318230201a.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Syeda L. Alqadri
    • 1
    Email author
  • Varun Sreenivasan
    • 2
  • Adnan I. Qureshi
    • 3
  1. 1.Department of NeurologyUniversity of Mississippi Medical CenterJacksonUSA
  2. 2.Department of MedicineKilpauk Medical CollegeKilpauk, ChennaiIndia
  3. 3.Department of NeurologyUniversity of MinnesotaMinneapolisUSA

Personalised recommendations